AddLife AB (CHIX:ALIFBS) Cyclically Adjusted Revenue per Share: kr61.63 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ALIFBS AddLife AB CHIX:ALIFBS
86 GF Score
Price kr159.05
GF Value kr147.90
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is AddLife AB Cyclically Adjusted Revenue per Share?

AddLife AB CHIX:ALIFBS 86 Cyclically Adjusted Revenue per Share is kr61.63 as of Jun. 2026. GuruFocus rates CHIX:ALIFBS with a GF Score™ of 86/100 and a GF Value™ of kr147.90 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

AddLife AB's adjusted revenue per share for the three months ended in Jun. 2026 was kr22.328. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr61.63 for the trailing ten years ended in Jun. 2026.

During the past 12 months, AddLife AB's average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-03), AddLife AB's current stock price is kr159.05. AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was kr61.63. AddLife AB's Cyclically Adjusted PS Ratio of today is 2.58.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of AddLife AB was 3.60. The lowest was 1.97. And the median was 2.76.


AddLife AB  (CHIX:ALIFBs) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AddLife AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=159.05/61.63
=2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of AddLife AB was 3.60. The lowest was 1.97. And the median was 2.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


AddLife AB Cyclically Adjusted Revenue per Share Related Terms


AddLife AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for AddLife AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB Cyclically Adjusted Revenue per Share Chart

AddLife AB Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 56.75 67.32

AddLife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.29 54.34 67.32 63.63 61.63

CHIX:ALIFBS vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted PS Ratio falls into.


CHIX:ALIFBS
86GF Score
AddLife AB CHIX:ALIFBS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AddLife AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AddLife AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=22.328/134.6100*134.6100
=22.328

Current CPI (Jun. 2026) = 134.6100.

AddLife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.958 101.138 5.268
201612 5.967 102.022 7.873
201703 5.620 102.022 7.415
201706 5.581 102.752 7.311
201709 5.054 103.279 6.587
201712 6.545 103.793 8.488
201803 5.880 103.962 7.613
201806 6.127 104.875 7.864
201809 5.725 105.679 7.292
201812 6.951 105.912 8.834
201903 7.920 105.886 10.068
201906 7.477 106.742 9.429
201909 7.132 107.214 8.954
201912 8.805 107.766 10.998
202003 9.351 106.563 11.812
202006 11.117 107.498 13.921
202009 11.058 107.635 13.829
202012 15.083 108.296 18.748
202103 15.363 108.360 19.085
202106 18.774 108.928 23.200
202109 15.171 110.338 18.508
202112 17.193 112.486 20.575
202203 21.174 114.825 24.822
202206 17.082 118.384 19.423
202209 17.150 122.296 18.877
202212 18.658 126.365 19.875
202303 20.051 127.042 21.246
202306 19.408 129.407 20.188
202309 19.031 130.224 19.672
202312 20.877 131.912 21.304
202403 21.090 132.205 21.474
202406 20.958 132.716 21.257
202409 19.235 132.304 19.570
202412 23.124 132.987 23.406
202503 22.172 132.825 22.470
202506 21.155 133.699 21.299
202509 19.932 133.480 20.101
202512 22.427 133.390 22.632
202603 21.705 133.560 21.876
202606 22.328 134.610 22.328

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr61.63 mean?
AddLife AB (CHIX:ALIFBS) has a Cyclically Adjusted Revenue per Share of kr61.63 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on AddLife AB and its competitors.
Is AddLife AB's Cyclically Adjusted Revenue per Share too high?
AddLife AB's current Cyclically Adjusted Revenue per Share is kr61.63. Overall, AddLife AB has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
AddLife AB's Cyclically Adjusted Revenue per Share of kr61.63 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on AddLife AB and its competitors. AddLife AB's current Cyclically Adjusted Revenue per Share is kr61.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
Based on GuruFocus' analysis, AddLife AB (CHIX:ALIFBS) is currently considered Fairly Valued. The stock's GF Value™ is kr147.90, compared to a current price of kr159.05 — trading 7.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr61.63. AddLife AB's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For AddLife AB (CHIX:ALIFBS), the current Cyclically Adjusted Revenue per Share is kr61.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AddLife AB (CHIX:ALIFBS) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of kr159.05 is trading 7.5% above its estimated GF Value™ of kr147.90. GuruFocus considers AddLife AB to be Fairly Valued.

Key valuation signals for CHIX:ALIFBS:

  • Cyclically Adjusted Revenue per Share: kr61.63
  • GF Value™: kr147.90 vs. price of kr159.05 (7.5% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ALIFBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
86GF Score

Get the complete analysis for CHIX:ALIFBS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr159.05
Price
kr147.90
GF Value